Minot Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

Minot Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$55K	Hold	50,000	–	–	0.01%	177
2022 Q1	$88K	Buy	+50,000	New	+$94.6K	0.02%	196
2021 Q4	–	Sell	-25,000	Closed	-$92K	–	219
2021 Q3	$92K	Hold	25,000	–	–	0.02%	199
2021 Q2	$152K	Sell	25,000 -47,230	-65%	-$295K	0.03%	195
2021 Q1	$426K	Sell	72,230 -60,053	-45%	-$406K	0.11%	127
2020 Q4	$803K	Buy	+132,283	New	+$924K	0.24%	89

Other funds holding ARDS

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

Minot Wealth Management's ARDS Position: Q2 2022 in Review

Minot Wealth Management held its Aridis Pharmaceuticals Inc. Common Stock (ARDS) position steady in Q2 2022 at 50,000 shares worth $55K. The position accounts for 0.01% of the portfolio, ranked #177.

Minot Wealth Management first reported a position in ARDS in Q4 2020 and has held it in 6 quarters since. The position peaked at $803K in Q4 2020. 19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

Minot Wealth Management held 50,000 shares of Aridis Pharmaceuticals Inc. Common Stock worth $55K as of Q2 2022.
Minot Wealth Management left its Aridis Pharmaceuticals Inc. Common Stock share count unchanged in Q2 2022.
Aridis Pharmaceuticals Inc. Common Stock made up 0.01% of Minot Wealth Management's portfolio in Q2 2022, its #177 holding.
Minot Wealth Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2020 and has held it in 6 quarters since.
Minot Wealth Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $803K in Q4 2020.
19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.